ALDAGEN INC

Profile

Company Names

ALDAGEN INC

Addresses

2810 MERIDIAN PARKWAY SUITE 148, DURHAM, NC 27713

Phone Numbers

919-484-2571

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$8,953,283.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2011-09-16 
$585,004.00 
$645,004.00 
$60,000.00 
Debt 
2
2011-06-20 
$1,080,377.00 
$1,080,377.00 
$0.00 
Debt 
1
2009-10-22 
$7,287,902.00 
$10,000,000.00 
$2,712,098.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
W. 
THOMAS 
AMICK 
EXECUTIVE OFFICER, DIRECTOR
ALDAGEN INC   |  BIOLEX THERAPEUTICS, INC.
ANDREW 
E. 
BALBER 
EXECUTIVE OFFICER
ALDAGEN INC
WILLIAM 
 
BROOKE 
DIRECTOR
INNOVATIVE BIOSENSORS INC   |  ALDAGEN INC   |  NCONTACT SURGICAL INC   |  MAXCYTE, INC.
WILLIAM 
W 
BROOKE 
DIRECTOR
HARBERT VENTURE PARTNERS II, L.P.   |  ALDAGEN INC   |  NCONTACT SURGICAL INC   |  HARBERT EUROPEAN REAL ESTATE FUND IV (SCOTLAND), L.P.   |  HARBERT EUROPEAN REAL ESTATE FUND IV, L.P.
DAVID 
 
CARBERRY 
EXECUTIVE OFFICER
ALDAGEN INC   |  TYME TECHNOLOGIES, INC.
B 
JEFFERSON 
CLARK 
DIRECTOR
ALDAGEN INC
B. 
JEFFERSON 
CLARK 
DIRECTOR
HYPERBRANCH MEDICAL TECHNOLOGY INC   |  ALDAGEN INC   |  ARGOS THERAPEUTICS INC   |  REGADO BIOSCIENCES INC   |  METABOLON, INC   |  ESSENTIAL HEALTH SOLUTIONS INC.   |  VERITAS COLLABORATIVE HOLDINGS, LLC   |  CUREATE, LLC   |  MATCHWELL, LLC   |  MATCHWELL, INC.   |  QUINSITE, INC.   |  GALAXY DIAGNOSTICS, INC.   |  PNEUMOCYTE LLC
DENNIS 
 
DOUGHERTY 
DIRECTOR
ARSENAL MEDICAL, INC.   |  NCONTACT SURGICAL INC   |  ABT MOLECULAR IMAGING, INC.   |  ALDAGEN INC   |  TRANSENTERIX INC   |  CODA HOLDINGS, INC.   |  SAFESTITCH MEDICAL, INC.   |  MAXCYTE, INC.   |  ADVANCED ANIMAL DIAGNOSTICS INC   |  480 BIOMEDICAL, INC.   |  MEMBERHUB, INC.   |  ARSENAL MEDICAL, INC.
WILLIAM 
 
EVANS 
DIRECTOR
SECUREWORKS HOLDING CORP   |  ALDAGEN INC   |  GOTRYITON, INC.   |  URTHECAST CORP.   |  ROCK HEALTH CAPITAL FUND I LP   |  BEACON TECH INC.
WILLIAM 
E. 
EVANS 
DIRECTOR
ALDAGEN INC
EDWARD 
 
FIELD 
EXECUTIVE OFFICER
ALDAGEN INC   |  BMH NORTH MISSISSIPPI IMAGING SERVICES LLC   |  CEREIUS, INC.
EDWARD 
L. 
FIELD 
EXECUTIVE OFFICER
ALDAGEN INC   |  BIORESTORATIVE THERAPIES, INC.
JAMES 
 
HINSON 
EXECUTIVE OFFICER
ALDAGEN INC
JIM 
 
HINSON 
EXECUTIVE OFFICER
ALDAGEN INC
LYLE 
A 
HOHKNE 
EXECUTIVE OFFICER, DIRECTOR
ALDAGEN INC
LYLE 
A. 
HOHNKE 
DIRECTOR, EXECUTIVE OFFICER
ALDAGEN INC
RICHARD 
 
KENT 
DIRECTOR
CEMPRA HOLDINGS, LLC   |  ALDAGEN INC   |  CSA MEDICAL INC   |  CYTOMEDIX INC   |  ESANEX, INC.   |  CEMPRA, INC.   |  VASCULAR PHARMACEUTICALS, INC.   |  AVISTONE NORTH HIGHLANDS, LLC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  CSA MEDICAL, INC.   |  BARINGS GLOBAL CREDIT FUND (LUX) SCSP, SICAV-SIF   |  BARINGS REAL ESTATE EUROPEAN VALUE ADD FUND II, A SUB-FUND OF BARINGS UMBRELLA FUND (LUX) SCSP SICAV-RAIF   |  BARINGS EUROPEAN REAL ESTATE DEBT INCOME FUND, A SUB-FUND OF BARINGS UMBRELLA FUND (LUX) SCSP SICAV-RAIF   |  AVISTONE TULSA, LLC
RICHARD 
S 
KENT 
DIRECTOR
ALDAGEN INC
JOEL 
 
KIMBROUGH 
DIRECTOR
ALDAGEN INC   |  ESSENTIAL HEALTH SOLUTIONS INC.   |  VERITAS COLLABORATIVE HOLDINGS, LLC   |  CELLARIAN HOLDINGS, INC.   |  GALAXY DIAGNOSTICS, INC.
JOEL 
R. 
KIMBROUGH 
DIRECTOR
ALDAGEN INC
GARHENG 
 
KONG 
DIRECTOR
CEMPRA HOLDINGS, LLC   |  APPLIED GENETIC TECHNOLOGIES CORP   |  VIAMET PHARMACEUTICALS INC   |  ALDAGEN INC   |  TRANSENTERIX INC   |  CANCERGUIDE DIAGNOSTICS, INC.   |  SARCODE BIOSCIENCE INC.   |  SOFINNOVA VENTURE PARTNERS VIII, L.P.   |  HISTOGENICS CORP   |  CEMPRA, INC.   |  ALIMERA SCIENCES INC   |  FIRST AID BEVERAGES, INC.   |  SOFINNOVA HEALTHQUEST PARTNERS, L.P.   |  TRICE MEDICAL, INC.   |  LONGWOOD OPPORTUNITY OFFSHORE FUND, LTD   |  LONGWOOD OFFSHORE, LTD.   |  CASTLE BIOSCIENCES INC   |  STRONGBRIDGE BIOPHARMA PLC   |  ACUTA OPPORTUNITY OFFSHORE FUND, LTD.   |  ACUTA CAPITAL OFFSHORE FUND, LTD.   |  HEALTHQUEST PARTNERS II, L.P.   |  MAGNOLIA MEDICAL TECHNOLOGIES, INC.   |  VENUS CONCEPT LTD.   |  ALCRESTA THERAPEUTICS, INC.   |  MELINTA THERAPEUTICS, INC. /NEW/   |  AVEDRO INC   |  CLEANSLATE CENTERS, INC.   |  BARDY DIAGNOSTICS, INC.   |  HEALTHQUEST PARTNERS III, L.P.   |  HEALTHQUEST AJAX II SPV, L.P.   |  AJAX HEALTH II LLC   |  VENUS CONCEPT INC.   |  HEALTHQUEST AJAX III SPV, L.P.   |  AJAX HEALTH III LLC   |  HEALTHQUEST AJAX III-A SPV, L.P.   |  HEALTHQUEST MADISON SPV, L.P.   |  HEALTHQUEST PARTNERS IV, L.P.   |  HEALTHQUEST TACTICAL OPPORTUNITIES FUND, L.P.   |  HOME HOSPITAL NEWCO, INC.   |  HQTOF ENDEAVOR SPV, L.P.   |  HQTOF ENDEAVOR SPV-B, L.P.   |  NOMAD HEALTH, INC.
MARTIN 
 
MURPHY 
DIRECTOR
ALDAGEN INC   |  JENNEREX, INC.   |  INTEGRATED ENDOSCOPY, INC.   |  CAMBRIDGE EPIGENETIX LTD   |  CLADE THERAPEUTICS, INC.   |  AUTOLUS THERAPEUTICS PLC
MARTIN 
J. 
MURPHY 
DIRECTOR
ALDAGEN INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-01-13
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2011-09-16 
2011-10-03
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2011-09-16 
2011-06-23
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2011-06-20 
2009-11-24
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2009-10-22 
2009-10-27
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2009-10-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#